DrugPatentWatch Database Preview
Details for Patent: 6,352,717
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
Which drugs does patent 6,352,717 protect, and when does it expire?
Patent 6,352,717 protects FORTOVASE and is included in one NDA.
Protection for FORTOVASE has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has forty patent family members in thirty-four countries.
Summary for Patent: 6,352,717
| Title: | Process for encapsulating shear sensitive fill masses into capsules and capsules containing shear sensitive fill masses |
| Abstract: | The present invention provides a process for encapsulating a shear sensitive fill mass which contains a pharmaceutical active agent or nutrient, characterized in that said fill mass is heated and subsequently cooled, prior to the encapsulation. The invention also provides capsules comprising shear sensitive fill material obtained by the said process which have a high and constant dissolution rate. |
| Inventor(s): | Alex; Rainer (Weil am Rhein, DE), Gerhards; Jurgen (Arlesheim, CH), Kraemer-Pittrof; Ingeborg (Rheinfelden, DE), Oeschger; Richard (Rheinsulz, CH), Rades; Thomas (Dunedin, NZ) |
| Assignee: | Hoffman-La Roche Inc. (Nutley, NJ) |
| Application Number: | 09/440,731 |
|
Patent Claim Types: see list of patent claims | Dosage form; Process; Formulation; |
Drugs Protected by US Patent 6,352,717
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hoffmann La Roche | FORTOVASE | saquinavir | CAPSULE;ORAL | 020828-001 | Nov 7, 1997 | DISCN | Yes | No | Start Trial | Start Trial | Y | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 6,352,717
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| 98121831 | Nov 17, 1998 | |
International Family Members for US Patent 6,352,717
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 020013 | Start Trial | |||
| Austria | 274895 | Start Trial | |||
| Australia | 1775100 | Start Trial | |||
| Australia | 751446 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
